Press Releases
SANTA MONICA, Calif.--(BUSINESS WIRE)-- Douglas Emmett, Inc. (NYSE: DEI), a real estate investment trust (REIT), has released its Third Quarter 2026 Earnings Results and Operating Information package by posting it to the investor relations section of its website at www.douglasemmett.com/investors.
As previously announced, Jordan Kaplan, Chairman & CEO, Peter Seymour, CFO, Kevin Crummy, CIO, and Stuart McElhinney, Vice President Investor Relations will host a live... (continue reading...)
JERSEY CITY, NJ / ACCESS Newswire / November 3, 2026 / Amdocs (NASDAQ: DOX) today announced a multi-year agreement with Magyar Telekom, one of Hungary's leading telecommunications service providers and a member of the Deutsche Telekom Group, to modernize its core business support systems through a comprehensive transformation of its billing, convergent charging and product catalog capabilities.
Under the multi-year agreement, Amdocs will deliver a comprehensive... (continue reading...)
(Albany, US), November 3, 2026 - DelveInsight's 'Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) – Market Insights, Epidemiology and Market Forecast – 2036' report delivers an in-depth understanding of PH-ILD,... (continue reading...)
(Albany, US), November 03, 2026 - DelveInsight's 'Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast – 2036' report delivers an in-depth understanding of Paroxysmal Nocturnal Hemoglobinuria (PNH), historical and forecasted epidemiology,... (continue reading...)
“Major Depressive Disorder Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights... (continue reading...)
More Press Releases
View Older Stories-
Mucopolysaccharidosis I Market Size in the 7MM is projected to grow at a CAGR of 8.6% over the forecast period of 2026-2036 | DelveInsight
-
Gene And Cell Therapies Targeting CNS Disorders Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight
-
EagleRock Announces Third Quarter 2026 Results
-
Global Industrial Reports Third Quarter 2026 Financial Results
-
Florida State University Announces Aerospace Research and Innovation Facility at The St. Joe Company's VentureCrossings® Enterprise Centre
-
Tidal Financial Group and GammaRoad Capital Partners Announce Closure of GMMA ETF
-
Prudential Financial, Inc. Announces Third Quarter 2026 Results
-
Oxbridge / SurancePlus / AI GridWorks to Attend and Speak at The PIPEs Conference 2026
-
Keith Dagostino Grant Launches Hofstra University Business Scholarship to Support Undergraduate Students Nationwide
-
AIG Delivers Strong Third Quarter Results
-
Bright MLS Integration with Ocusell Network Goes Live, Expanding Multi-MLS Publishing Across the Mid-Atlantic and Unveiling OneList Listing Platform
-
Postal Realty Trust, Inc. Reports Third Quarter 2026 Results
-
PCDJ releases DEX 4.1 with AI beat mapping and smarter track selection
-
Redwood Trust Plans C-Corporation Conversion and Preferred-for-Common Stock Exchange Offer at a Premium
-
Valmont to Participate in Baird’s 2026 Global Industrial Conference
-
Globe Expands Strategic Collaboration with Amdocs to Modernize Core Platforms and Strengthen IT Operations
-
Pantera Silver Announces Resumption of Trading on the TSX Venture Exchange
-
Kodak Reports Third-Quarter 2026 Financial Results
-
Omega Reports Third Quarter 2026 Results and Recent Developments
-
Matador Resources Company Reports Third Quarter 2026 Results Including Record Oil Production and Continued Debt Repayment
-
Fuel Tech Reports 2026 Third Quarter Financial Results; Outlines Framework for Sustainable Growth and Value Creation
-
LTC Reports 2026 Third Quarter Results as SHOP Momentum Continues
-
IFF Reports Third Quarter 2026 Results
-
RYAM Reports Third Quarter 2026 Results
-
Graft-Versus Host Disease Market Size, Share, Trends, and Growth Analysis: Strong Expansion Expected by 2034 | Syndax Pharma, Abbisko Therapeutics, Theriva Biologics, Seres Therapeutics, Cellestia Bio
-
Chronic Hand Eczema Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and Route of Administration Trends | Incyte Corp, LEO Pharma, Asana BioSciences, Arcutis Biotherapeutics
-
Polycythemia Vera Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therape
-
BK Virus Infection Market Is Set to Transform by 2036: Top Trends, Key Players, and Revenue Forecast Revealed | Ipsen, Memo Therapeutics, AlloVir, Veru Therapeutics, Memo Therapeutics, AiCuris
-
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Par Pacific Holdings Reports Third Quarter 2026 Results
-
Jack Henry & Associates, Inc. Reports First Quarter Fiscal 2027 Results
-
CPS Technologies Announces Third Quarter 2026 Financial Results
-
Dover to Present at the Baird 2026 Global Industrial Conference
-
NextNav to Participate in November 2026 Conferences
-
Jackson Announces Outstanding Third Quarter 2026 Results
-
Mosaic Announces Third Quarter 2026 Results
-
Sun Nuclear Debuts Simon, a Command Center for Linac Health in Radiation Oncology
-
Redwood Trust Reports Third Quarter Financial Results and Announces Planned Transition to a C-corporation
-
Mayville Engineering Company Announces Third Quarter 2026 Results
-
PACS Group, Inc. Reports Third Quarter 2026 Results
-
BRAEMAR HOTELS & RESORTS ANNOUNCES CLOSING ON SALE OF FOUR SEASONS RESORT SCOTTSDALE
-
Talos Energy Announces Third Quarter 2026 Operational and Financial Results
-
Pelagos Insurance Capital Expands Capital Management Initiatives
-
HP Inc. to Announce Fourth Quarter Fiscal 2026 Earnings on November 24, 2026 and to Attend Upcoming Investor Conferences
-
First American Financial Corporation Declares Quarterly Cash Dividend of 61 Cents Per Share
-
Accel Entertainment Reports Record Third Quarter Revenue of $364 Million
-
Seadrill Announces Third Quarter 2026 Results
-
Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2026
-
Modine Reports Second Quarter Fiscal 2027 Results
-
Polestar Provides an Update on the Q3 2026 Reporting Date


